ZLTQ - Zeltiq Aesthetics Stock Price, News & Analysis

$56.48 0.00 (0.00 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$56.48
Today's Range$56.48 - $56.49
52-Week Range$23.58 - $56.50
Volume3.12 million shs
Average Volume1.53 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Zeltiq Aesthetics (NASDAQ:ZLTQ)

Zeltiq Aesthetics logoZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company's product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.


Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:ZLTQ
CUSIP98933Q10

Debt

Debt-to-Equity RatioN/A
Current Ratio2.01%
Quick Ratio1.57%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS($0.03)
Net IncomeN/A
Net Margins9.78%
Return on Equity31.74%
Return on Assets20.11%

Miscellaneous

Employees535
Outstanding Shares40,540,000

Frequently Asked Questions for Zeltiq Aesthetics (NASDAQ:ZLTQ)

What is Zeltiq Aesthetics' stock symbol?

Zeltiq Aesthetics trades on the NASDAQ under the ticker symbol "ZLTQ."

How were Zeltiq Aesthetics' earnings last quarter?

Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) announced its quarterly earnings results on Monday, August, 8th. The medical equipment provider reported ($0.12) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.07. The medical equipment provider earned $89.50 million during the quarter, compared to the consensus estimate of $79.68 million. Zeltiq Aesthetics had a net margin of 9.78% and a return on equity of 31.74%. The firm's revenue for the quarter was up 38.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.03 earnings per share. View Zeltiq Aesthetics' Earnings History.

Where is Zeltiq Aesthetics' stock going? Where will Zeltiq Aesthetics' stock price be in 2017?

9 analysts have issued 1 year price objectives for Zeltiq Aesthetics' shares. Their forecasts range from $56.00 to $58.00. On average, they expect Zeltiq Aesthetics' share price to reach $56.83 in the next year. View Analyst Ratings for Zeltiq Aesthetics.

Who are some of Zeltiq Aesthetics' key competitors?

Who are Zeltiq Aesthetics' key executives?

Zeltiq Aesthetics' management team includes the folowing people:

  • Mark J. Foley, President, Chief Executive Officer (Age 51)
  • Taylor C. Harris, Chief Financial Officer, Senior Vice President (Age 41)
  • Brent Hauser, President - North America (Age 40)
  • Todd E. Zavodnick, President - International (Age 45)
  • Sergio Garcia, Senior Vice President, General Counsel and Corporate Secretary (Age 55)
  • Mike Fitzgerald, Senior Vice President - Global Human Resources (Age 57)
  • Danika R. Harrison, Vice President - Global Marketing (Age 41)
  • Carl H. Lamm, Vice President of Operations (Age 55)
  • Brad Hauser, Vice President - Research and Development (Age 40)

How do I buy Zeltiq Aesthetics stock?

Shares of Zeltiq Aesthetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zeltiq Aesthetics' stock price today?

One share of Zeltiq Aesthetics stock can currently be purchased for approximately $56.48.

How can I contact Zeltiq Aesthetics?

Zeltiq Aesthetics' mailing address is 4410 Rosewood Dr, PLEASANTON, CA 94588-3050, United States. The medical equipment provider can be reached via phone at +1-925-4742500.


MarketBeat Community Rating for Zeltiq Aesthetics (ZLTQ)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  321 (Vote Outperform)
Underperform Votes:  183 (Vote Underperform)
Total Votes:  504
MarketBeat's community ratings are surveys of what our community members think about Zeltiq Aesthetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Zeltiq Aesthetics (NASDAQ:ZLTQ)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.172.172.172.23
Ratings Breakdown: 0 Sell Ratings
10 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
10 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
10 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
10 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings
Consensus Price Target: $49.21$48.06$46.83$46.83
Price Target Upside: 12.90% downside14.93% downside17.11% downside17.11% downside

Consensus Price Target History for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Price Target History for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Analysts' Ratings History for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/24/2017AegisReiterated RatingHold$56.00LowView Rating Details
3/10/2017Canaccord GenuityReiterated RatingHold$56.50N/AView Rating Details
3/2/2017Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
2/14/2017Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
2/14/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017Maxim GroupDowngradeBuy -> HoldN/AView Rating Details
2/13/2017Northland SecuritiesReiterated RatingPositiveN/AView Rating Details
2/13/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/9/2016J P Morgan Chase & CoReiterated RatingHold$27.00 -> $35.00N/AView Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Boost Price Target$35.00 -> $37.00N/AView Rating Details
1/22/2016Griffin SecuritiesUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Earnings by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Earnings History by Quarter for Zeltiq Aesthetics (NASDAQ ZLTQ)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q316$0.08$0.12$90.84 million$95.20 millionViewListenView Earnings Details
8/8/2016Q216($0.05)($0.12)$79.68 million$89.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.25)($0.25)$61.80 million$64.50 millionViewListenView Earnings Details
2/29/2016Q415$0.12$0.99$77.17 million$78.20 millionViewListenView Earnings Details
10/27/2015Q315($0.05)$0.05$58.18 million$61.20 millionViewListenView Earnings Details
7/30/2015Q215($0.04)$0.03$57.57 million$64.40 millionViewListenView Earnings Details
5/5/2015Q115($0.12)($0.06)$48.20 million$51.60 millionViewN/AView Earnings Details
3/3/2015Q414$0.01$0.03$50.70 million$50.80 millionViewN/AView Earnings Details
10/28/2014Q314($0.08)$0.12$40.20 million$45.70 millionViewN/AView Earnings Details
7/29/2014Q214($0.13)$0.07$34.93 million$47.10 millionViewN/AView Earnings Details
4/29/2014Q114($0.15)($0.20)$27.54 million$31.00 millionViewN/AView Earnings Details
2/25/2014Q413($0.12)($0.15)$33.28 million$35.80 millionViewN/AView Earnings Details
10/30/2013Q313($0.19)($0.08)$21.30 million$29.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.22)($0.15)$20.62 million$17.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zeltiq Aesthetics (NASDAQ:ZLTQ)
2017 EPS Consensus Estimate: $0.27
2018 EPS Consensus Estimate: $0.76
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174($0.21)($0.09)($0.14)
Q2 20174($0.08)$0.07$0.01
Q3 20174$0.16$0.28$0.20
Q4 20174$0.10$0.30$0.20
Q1 20181($0.03)($0.03)($0.03)
Q2 20181$0.17$0.17$0.17
Q3 20181$0.30$0.30$0.30
Q4 20181$0.32$0.32$0.32
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Zeltiq Aesthetics (NASDAQ:ZLTQ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Zeltiq Aesthetics (NASDAQ ZLTQ)

Insider Ownership Percentage: 15.60%
Insider Trades by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Insider Trades by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Insider Trades by Quarter for Zeltiq Aesthetics (NASDAQ ZLTQ)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/13/2017Mark J FoleyInsiderSell10,000$55.77$557,700.00View SEC Filing  
2/21/2017Bradley HauserSVPSell3,000$55.64$166,920.00View SEC Filing  
1/13/2017Mark J FoleyInsiderSell10,000$41.72$417,200.00View SEC Filing  
1/4/2017Keith J SullivanInsiderSell8,000$44.36$354,880.00View SEC Filing  
12/13/2016Mark J FoleyInsiderSell10,000$44.08$440,800.00View SEC Filing  
12/8/2016Carl LammVPSell21,600$45.00$972,000.00View SEC Filing  
12/5/2016Keith J SullivanInsiderSell8,000$43.78$350,240.00View SEC Filing  
11/14/2016Mark J FoleyInsiderSell10,000$39.54$395,400.00View SEC Filing  
11/4/2016Keith J SullivanInsiderSell8,000$33.01$264,080.00View SEC Filing  
10/17/2016Sergio GarciaVPSell20,000$39.08$781,600.00View SEC Filing  
10/13/2016Mark J FoleyInsiderSell10,000$40.55$405,500.00View SEC Filing  
10/4/2016Keith J SullivanInsiderSell8,000$38.84$310,720.00View SEC Filing  
9/15/2016Carl LammVPSell3,125$40.00$125,000.00View SEC Filing  
9/15/2016Kevin C OboyleDirectorSell7,500$40.08$300,600.00View SEC Filing  
9/13/2016Mark J FoleyInsiderSell10,000$37.69$376,900.00View SEC Filing  
9/12/2016Bradley HauserVPSell3,000$37.33$111,990.00View SEC Filing  
9/6/2016Keith J SullivanInsiderSell8,000$38.36$306,880.00View SEC Filing  
8/15/2016Mark J FoleyInsiderSell10,000$37.26$372,600.00View SEC Filing  
8/11/2016Andrew N SchiffDirectorSell500,000$36.39$18,195,000.00View SEC Filing  
8/9/2016Kevin C OboyleDirectorSell17,500$37.86$662,550.00View SEC Filing  
8/9/2016Mark J FoleyInsiderSell50,000$37.89$1,894,500.00View SEC Filing  
8/5/2016Mark J FoleyInsiderSell50,000$35.01$1,750,500.00View SEC Filing  
8/4/2016Keith J SullivanInsiderSell8,000$34.37$274,960.00View SEC Filing  
7/13/2016Mark J FoleyCEOSell10,000$31.21$312,100.00View SEC Filing  
7/11/2016Bradley HauserVPSell3,000$30.02$90,060.00View SEC Filing  
7/11/2016Keith J SullivanInsiderSell8,000$30.02$240,160.00View SEC Filing  
4/13/2016Mark J FoleyCEOSell13,640$29.39$400,879.60View SEC Filing  
4/13/2016Mary FisherDirectorSell1,863$30.00$55,890.00View SEC Filing  
4/13/2016Sergio GarciaVPSell5,000$30.00$150,000.00View SEC Filing  
3/22/2016Mark J FoleyCEOSell9,698$25.01$242,546.98View SEC Filing  
3/21/2016Mark J FoleyCEOSell17,574$25.03$439,877.22View SEC Filing  
1/13/2016Mark J. FoleyCEOSell13,636$26.39$359,854.04View SEC Filing  
12/14/2015Mark J. FoleyCEOSell13,636$28.03$382,217.08View SEC Filing  
12/8/2015Mary FisherDirectorSell30,000$30.13$903,900.00View SEC Filing  
12/4/2015Leonard C. DebenedictisinsiderSell2,708$30.76$83,298.08View SEC Filing  
11/23/2015Andrew N SchiffDirectorSell255,992$30.73$7,866,634.16View SEC Filing  
11/19/2015Andrew N SchiffDirectorSell244,008$30.77$7,508,126.16View SEC Filing  
11/17/2015Carl LammVPSell2,341$31.66$74,116.06View SEC Filing  
11/13/2015Mark J. FoleyCEOSell13,636$32.17$438,670.12View SEC Filing  
11/13/2015Sergio GarciaVPSell5,000$31.92$159,600.00View SEC Filing  
11/4/2015Keith J. SullivanSVPSell1,200$34.28$41,136.00View SEC Filing  
11/2/2015Leonard C. DebenedictisinsiderSell10,479$33.92$355,447.68View SEC Filing  
10/13/2015Mark J. FoleyCEOSell13,636$31.80$433,624.80View SEC Filing  
10/5/2015Keith J. SullivanSVPSell13,700$32.60$446,620.00View SEC Filing  
10/1/2015Leonard C. DebenedictisinsiderSell2,709$31.91$86,444.19View SEC Filing  
9/14/2015Mark J. FoleyCEOSell13,636$35.30$481,350.80View SEC Filing  
9/4/2015Keith J. SullivanSVPSell13,700$31.62$433,194.00View SEC Filing  
9/1/2015Leonard C. DebenedictisinsiderSell2,708$31.60$85,572.80View SEC Filing  
8/13/2015Mark J FoleyCEOSell13,636$35.02$477,532.72View SEC Filing  
7/24/2015Kevin C OboyleDirectorSell3,900$33.00$128,700.00View SEC Filing  
7/14/2015Keith J SullivanSVPSell12,500$30.06$375,750.00View SEC Filing  
7/14/2015Leonard C DebenedictisInsiderSell1,563$30.00$46,890.00View SEC Filing  
7/13/2015Mark J FoleyCEOSell13,636$28.95$394,762.20View SEC Filing  
7/1/2015Leonard C DebenedictisInsiderSell1,146$30.00$34,380.00View SEC Filing  
6/25/2015Keith J SullivanSVPSell1,200$32.00$38,400.00View SEC Filing  
6/17/2015Keith J SullivanSVPSell12,500$30.00$375,000.00View SEC Filing  
6/17/2015Leonard C DebenedictisInsiderSell2,708$30.00$81,240.00View SEC Filing  
6/17/2015Patrick F WilliamsCFOSell22,045$30.00$661,350.00View SEC Filing  
6/17/2015Sergio GarciaVPSell10,000$30.00$300,000.00View SEC Filing  
6/15/2015Mark J FoleyCEOSell13,636$27.85$379,762.60View SEC Filing  
4/1/2015Leonard C DebenedictisInsiderSell2,709$30.22$81,865.98View SEC Filing  
3/2/2015Leonard C DebenedictisInsiderSell4,269$33.47$142,883.43View SEC Filing  
2/23/2015Carl LammVPSell2,315$34.16$79,080.40View SEC Filing  
2/17/2015Mark J FoleyCEOSell7,123$34.30$244,318.90View SEC Filing  
2/6/2015Carl LammVPSell6,205$35.00$217,175.00View SEC Filing  
2/5/2015Keith J SullivanSVPSell1,258$34.00$42,772.00View SEC Filing  
2/2/2015Leonard C DebenedictisInsiderSell5,125$31.46$161,232.50View SEC Filing  
1/26/2015Mary FisherDirectorSell52,602$32.18$1,692,732.36View SEC Filing  
1/20/2015Mark J FoleyCEOSell36,400$30.35$1,104,740.00View SEC Filing  
1/15/2015Jean GeorgeDirectorSell17,483$29.26$511,552.58View SEC Filing  
1/14/2015Mark J FoleyCEOSell7,123$29.25$208,347.75View SEC Filing  
1/12/2015Mark J FoleyCEOSell36,500$30.16$1,100,840.00View SEC Filing  
1/9/2015Keith J SullivanSVPSell1,200$30.00$36,000.00View SEC Filing  
1/9/2015Leonard C DebenedictisInsiderSell3,400$30.00$102,000.00View SEC Filing  
1/9/2015Patrick F WilliamsCFOSell10,400$30.21$314,184.00View SEC Filing  
1/9/2015Sergio GarciaVPSell1,647$30.00$49,410.00View SEC Filing  
1/5/2015Keith J SullivanSVPSell1,008$26.20$26,409.60View SEC Filing  
1/5/2015Sergio GarciaVPSell1,500$26.20$39,300.00View SEC Filing  
1/2/2015Leonard C DebenedictisInsiderSell3,400$27.63$93,942.00View SEC Filing  
12/18/2014Keith J SullivanSVPSell1,050$30.00$31,500.00View SEC Filing  
12/18/2014Leonard C DebenedictisInsiderSell41,073$30.00$1,232,190.00View SEC Filing  
12/18/2014Patrick F WilliamsCFOSell2,100$30.00$63,000.00View SEC Filing  
12/18/2014Sergio GarciaVPSell2,040$30.00$61,200.00View SEC Filing  
12/15/2014Mark J FoleyCEOSell7,123$28.97$206,353.31View SEC Filing  
12/5/2014Keith J SullivanSVPSell1,008$26.81$27,024.48View SEC Filing  
12/1/2014Leonard C DebenedictisInsiderSell3,400$26.55$90,270.00View SEC Filing  
11/20/2014Patrick F WilliamsCFOSell11,000$28.45$312,950.00View SEC Filing  
11/19/2014Sergio GarciaVPSell1,500$27.95$41,925.00View SEC Filing  
11/14/2014Mark J FoleyCEOSell7,123$26.92$191,751.16View SEC Filing  
11/5/2014Keith J SullivanSVPSell1,008$26.59$26,802.72View SEC Filing  
11/3/2014Carl LammVPSell1,808$25.19$45,543.52View SEC Filing  
11/3/2014Jean GeorgeDirectorSell17,483$25.15$439,697.45View SEC Filing  
11/3/2014Leonard C DebenedictisInsiderSell6,443$25.14$161,977.02View SEC Filing  
10/29/2014Mark J FoleyCEOSell25,000$25.81$645,250.00View SEC Filing  
10/27/2014Leonard C DebenedictisInsiderSell3,400$24.00$81,600.00View SEC Filing  
10/14/2014Mark J FoleyCEOSell7,123$21.61$153,928.03View SEC Filing  
10/1/2014Carl LammVPSell1,807$22.30$40,296.10View SEC Filing  
9/15/2014Mark J FoleyCEOSell57,123$25.52$1,457,778.96View SEC Filing  
9/11/2014Kevin C OboyleDirectorSell5,000$25.50$127,500.00View SEC Filing  
9/11/2014Patrick F WilliamsCFOSell8,000$25.48$203,840.00View SEC Filing  
9/11/2014Sergio GarciaSVPSell3,250$25.00$81,250.00View SEC Filing  
9/10/2014Leonard C DebenedictisCTOSell17,100$24.00$410,400.00View SEC Filing  
9/2/2014Carl LammVPSell1,807$21.36$38,597.52View SEC Filing  
8/14/2014Mark J FoleyCEOSell7,123$19.57$139,397.11View SEC Filing  
8/1/2014Carl LammVPSell2,291$20.18$46,232.38View SEC Filing  
7/31/2014Jean GeorgeDirectorSell29,157$20.09$585,764.13View SEC Filing  
7/30/2014Carl LammVPSell4,580$20.23$92,653.40View SEC Filing  
7/30/2014Kevin C OboyleDirectorSell5,000$21.08$105,400.00View SEC Filing  
7/30/2014Leonard C DebenedictisCTOSell2,500$20.23$50,575.00View SEC Filing  
7/30/2014Mark J FoleyCEOSell21,269$21.50$457,283.50View SEC Filing  
7/30/2014Sergio GarciaSVPSell1,250$21.01$26,262.50View SEC Filing  
6/2/2014Patrick F WilliamsCFOSell1,000$17.17$17,170.00View SEC Filing  
5/1/2014Carl LammVPSell2,290$18.01$41,242.90View SEC Filing  
5/1/2014Leonard DebenedictisCTOSell2,500$18.01$45,025.00View SEC Filing  
4/16/2014Mark FoleyCEOSell7,123$18.05$128,570.15View SEC Filing  
4/10/2014Leonard DebenedictisCTOSell10,071$18.61$187,421.31View SEC Filing  
4/1/2014Carl LammVPSell2,290$19.83$45,410.70View SEC Filing  
4/1/2014Patrick WilliamsCFOSell5,000$20.26$101,300.00View SEC Filing  
3/4/2014Kevin OboyleDirectorSell15,000$19.31$289,650.00View SEC Filing  
1/21/2014Jean Georgemajor shareholderSell31,080$22.62$703,029.60View SEC Filing  
1/17/2014Carl LammVPSell11,740$23.39$274,598.60View SEC Filing  
11/18/2013Carl LammVPSell2,347$15.41$36,167.27View SEC Filing  
11/14/2013Andrew SchiffDirectorSell575,000$12.22$7,026,500.00View SEC Filing  
10/4/2013Carl LammVPSell1,624$9.00$14,616.00View SEC Filing  
6/17/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View SEC Filing  
5/21/2013Sergio GarciaVPSell7,688$5.00$38,440.00View SEC Filing  
4/29/2013Keith J SullivanSVPBuy15,000$4.67$70,050.00View SEC Filing  
4/23/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View SEC Filing  
8/7/2012Bryan E RobertsDirectorBuy685,000$5.00$3,425,000.00View SEC Filing  
8/6/2012Bryan E RobertsDirectorBuy60,000$4.72$283,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Zeltiq Aesthetics (NASDAQ ZLTQ)

Source:
DateHeadline
Zeltiq Aesthetics (ZLTQ) and Cogentix Medical (CGNT) Head to Head SurveyZeltiq Aesthetics (ZLTQ) and Cogentix Medical (CGNT) Head to Head Survey
www.americanbankingnews.com - November 21 at 9:46 PM
Critical Comparison: Zeltiq Aesthetics (ZLTQ) vs. Its RivalsCritical Comparison: Zeltiq Aesthetics (ZLTQ) vs. Its Rivals
www.americanbankingnews.com - November 15 at 3:30 PM
Comparing Zeltiq Aesthetics (ZLTQ) and Its CompetitorsComparing Zeltiq Aesthetics (ZLTQ) and Its Competitors
www.americanbankingnews.com - November 14 at 1:36 PM
Comparing Zeltiq Aesthetics (ZLTQ) & The CompetitionComparing Zeltiq Aesthetics (ZLTQ) & The Competition
www.americanbankingnews.com - October 31 at 9:16 PM
Comparing Zeltiq Aesthetics (ZLTQ) and The CompetitionComparing Zeltiq Aesthetics (ZLTQ) and The Competition
www.americanbankingnews.com - October 29 at 5:18 AM
Zimmer Biomet (ZBH) Beats on Q1 Earnings, Lowers GuidanceZimmer Biomet (ZBH) Beats on Q1 Earnings, Lowers Guidance
finance.yahoo.com - October 6 at 1:10 PM
Mead Johnson (MJN) Lags Q1 Earnings, Awaits Merger ClosureMead Johnson (MJN) Lags Q1 Earnings, Awaits Merger Closure
finance.yahoo.com - October 6 at 1:10 PM
Abaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In LineAbaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In Line
finance.yahoo.com - October 6 at 1:09 PM
ResMed (RMD) Beats Q3 Earnings, Misses Sales EstimatesResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates
finance.yahoo.com - October 6 at 1:09 PM
IDEXX Laboratories (IDXX) Beats Q1 Earnings, Raises ViewIDEXX Laboratories (IDXX) Beats Q1 Earnings, Raises View
finance.yahoo.com - October 6 at 1:09 PM
Revance Appoints Mark Foley to its Board of Directors - Business Wire (press release)Revance Appoints Mark Foley to its Board of Directors - Business Wire (press release)
www.businesswire.com - September 6 at 8:23 PM
Critical Comparison: Illumina (ILMN) vs. Zeltiq Aesthetics (ZLTQ)Critical Comparison: Illumina (ILMN) vs. Zeltiq Aesthetics (ZLTQ)
www.americanbankingnews.com - September 5 at 6:02 PM
Botox-maker Allergan quarterly revenue rises 9 pct - NasdaqBotox-maker Allergan quarterly revenue rises 9 pct - Nasdaq
www.nasdaq.com - August 4 at 10:17 AM
Botox-maker Allergan quarterly revenue rises 9 percent - ReutersBotox-maker Allergan quarterly revenue rises 9 percent - Reuters
www.reuters.com - August 3 at 9:13 AM
Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) Given Consensus Recommendation of "Hold" by BrokeragesZeltiq Aesthetics Inc (NASDAQ:ZLTQ) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 9:56 AM
Align (ALGN) Upgraded to Buy on Invisalign System ProspectsAlign (ALGN) Upgraded to Buy on Invisalign System Prospects
www.zacks.com - April 13 at 8:55 AM
Pre-Market Most Active for Apr 6, 2017 : BSBR, MT, MBLY, ZLTQ, BAC, QQQ, XIV, JAZZ, FTR, CHK, SKM, SGYP - NasdaqPre-Market Most Active for Apr 6, 2017 : BSBR, MT, MBLY, ZLTQ, BAC, QQQ, XIV, JAZZ, FTR, CHK, SKM, SGYP - Nasdaq
www.nasdaq.com - April 7 at 1:43 PM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against ZELTIQ Aesthetics, Inc.SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against ZELTIQ Aesthetics, Inc.
feeds.benzinga.com - April 4 at 12:26 PM
QIAGEN Offers JAK2 Kit in US, Grows in Molecular DiagnosticsQIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics
www.zacks.com - March 30 at 8:35 AM
How These Medical Equipment Stocks are Faring? -- Zimmer Biomet, ZELTIQ ...How These Medical Equipment Stocks are Faring? -- Zimmer Biomet, ZELTIQ ...
www.prnewswire.com - March 29 at 8:15 AM
ZELTIQ AESTHETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsZELTIQ AESTHETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - March 16 at 8:52 AM
ZELTIQ AESTHETICS MERGER ALERT – Andrews & Springer LLC Is Investigating ZELTIQ Aesthetics, Inc. For Potential Breaches of Fiduciary DutyZELTIQ AESTHETICS MERGER ALERT – Andrews & Springer LLC Is Investigating ZELTIQ Aesthetics, Inc. For Potential Breaches of Fiduciary Duty
feeds.benzinga.com - March 15 at 8:06 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ - PR Newswire (press release)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ - PR Newswire (press release)
www.prnewswire.com - March 10 at 7:04 AM
ZELTIQ Aesthetics (ZLTQ) to Showcase CoolAdvantage Petite applicator at AAD Meeting - StreetInsider.comZELTIQ Aesthetics (ZLTQ) to Showcase CoolAdvantage Petite applicator at AAD Meeting - StreetInsider.com
www.streetinsider.com - March 5 at 8:00 AM
ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial ResultsZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results
us.rd.yahoo.com - March 2 at 6:40 AM
ZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
us.rd.yahoo.com - March 2 at 6:40 AM
[$$] Gormleys Take: Body Beautification Is Sexy Business[$$] Gormley's Take: Body Beautification Is Sexy Business
www.wsj.com - February 22 at 10:50 AM
Medtronic Earnings Rebound in Third Quarter, Shares ClimbMedtronic Earnings Rebound in Third Quarter, Shares Climb
www.thestreet.com - February 21 at 4:21 PM
ZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrincipaZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa
biz.yahoo.com - February 17 at 9:25 AM
ZELTIQ Aesthetics downgraded by Leerink Partners and Canaccord GenuityZELTIQ Aesthetics downgraded by Leerink Partners and Canaccord Genuity
us.rd.yahoo.com - February 15 at 7:04 AM
Allergan to buy Zeltiq Aesthetics for about $2.48 billionAllergan to buy Zeltiq Aesthetics for about $2.48 billion
www.reuters.com - February 14 at 7:18 AM
ZELTIQ Aesthetics Inc. (ZLTQ) Set A New High After Purchased By AllerganZELTIQ Aesthetics Inc. (ZLTQ) Set A New High After Purchased By Allergan
www.rttnews.com - February 14 at 7:18 AM
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 blnAllergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln
us.rd.yahoo.com - February 14 at 7:18 AM
ZELTIQ AESTHETICS INC Files SEC form 8-K, Other EventsZELTIQ AESTHETICS INC Files SEC form 8-K, Other Events
us.rd.yahoo.com - February 14 at 7:17 AM
Harwood Feffer LLP Announces Investigation of ZELTIQ Aesthetics, Inc.Harwood Feffer LLP Announces Investigation of ZELTIQ Aesthetics, Inc.
us.rd.yahoo.com - February 14 at 7:17 AM

Social Media

Financials

Chart

Zeltiq Aesthetics (NASDAQ ZLTQ) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.